Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 21, 2019

SELL
$8.57 - $10.72 $4,285 - $5,360
-500 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$18.6 - $24.94 $5,580 - $7,482
-300 Reduced 37.5%
500 $10,000
Q4 2017

Feb 12, 2018

SELL
$20.9 - $49.36 $14,629 - $34,552
-700 Reduced 46.67%
800 $18,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,500
1,500 $53,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $154M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track York Bridge Wealth Partners, LLC Portfolio

Follow York Bridge Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.